ReviewCureus2025
Extracellular Matrix and Amniotic Derivatives in Bone and Nerve Repair: A Narrative Review of Mechanisms and Their Preclinical and Clinical Applications.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular matrix (ECM) and amniotic derivatives have emerged as promising biomaterials in regenerative medicine, particularly for bone and nerve repair. These biologic scaffolds provide structural and biochemical cues that support cellular migration, proliferation, and differentiation, thereby facilitating tissue regeneration. ECM-based therapies leverage native bioactive components to modulate immune responses and enhance healing, while perinatal derivatives, including amniotic membrane, umbilical cord, and placental tissue, offer a rich source of growth factors, cytokines, and stem cells that promote neurogenesis and osteogenesis. This literature review explores the mechanistic underpinnings of ECM and perinatal derivatives in bone and nerve repair, detailing their role in cellular signaling, inflammation modulation, and extracellular microenvironment remodeling. Furthermore, we discuss current preclinical and clinical applications, evaluating their efficacy in enhancing functional recovery in orthopedic and neurosurgical contexts. While these therapies hold immense potential, challenges like standardization, immunogenicity, and clinical translation remain key areas for future research. By integrating ECM and perinatal-based approaches, regenerative medicine can advance toward more effective, biologically driven solutions for complex bone and nerve injuries.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.